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Abstract
The exponential development of Patient-Reported Outcomes (PRO) measures in clinical research
has led to the creation of the Patient-Reported Outcome and Quality of Life Instruments Database
(PROQOLID) to facilitate the selection process of PRO measures in clinical research. The project
was initiated by Mapi Research Trust in Lyon, France. Initially called QOLID (Quality of Life
Instruments Database), the project's purpose was to provide all those involved in health care
evaluation with a comprehensive and unique source of information on PRO and HRQOL measures
available through the Internet.
PROQOLID currently describes more than 470 PRO instruments in a structured format. It is
available in two levels, non-subscribers and subscribers, at http://www.proqolid.org. The first level
is free of charge and contains 14 categories of basic useful information on the instruments (e.g.
author, objective, original language, list of existing translations, etc.). The second level provides
significantly more information about the instruments. It includes review copies of over 350 original
instruments, 120 user manuals and 350 translations. Most are available in PDF format. This level is
only accessible to annual subscribers. PROQOLID is updated in close collaboration with the
instruments' authors on a regular basis. Fifty or more new instruments are added to the database
annually.
Today, all of the major pharmaceutical companies, prestigious institutions (such as the FDA, the
NIH's National Cancer Institute, the U.S. Veterans Administration), dozens of universities, public
institutions and researchers subscribe to PROQOLID on a yearly basis. More than 800 users per
day routinely visit the database.
Review
In clinical research it has become increasingly common to
assess the patients' perspective of their symptoms and
their impact on their daily life as a tool for determining
treatment and a means of evaluating the outcome of the
treatment chosen [1,2]. The added value of measuring
Patient-Reported Outcomes (PRO) starts to be recognized
by key players in the field of clinical research [3]. How
patients perceive their health, and the impact of their
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treatment on their life can provide insight to clinicians
previously unavailable [4-6].
However the successful application of PRO studies is
dependant on the selection of the appropriate question-
naires for a given application [7,8]. They must be selected
according to the domains they measure and the popula-
tions and pathologies for which they are designed. Practi-
cal issues, such as the availability of different translations,
copyrights, and access to instruments are also major crite-
ria in the choice of instruments.
The search for the most appropriate instruments is hin-
dered by the substantial increase of PRO questionnaires
developed in the past ten years. A recent search on
PubMed, matching "quality of life" and "questionnaires"
shows a striking growth of 450% between the last two dec-
ades (Figure 1).
In order to facilitate the selection process the project of a
Patient-Reported Outcome and Quality of Life Instru-
ments Database (PROQOLID) was initiated by Mapi
Research Trust in Lyon, France. Initially called QOLID
(Quality of Life Instruments Database), the project's pur-
pose was to provide all those involved in health care eval-
uation with a comprehensive and unique source of
information on PRO and Health-Related Quality of Life
(HRQOL) measures available through the Internet. In col-
laboration with Dr. Marcello Tamburini (Director, Unit of
Psychology, National Cancer Institute, Milan, Italy), the
developer of the QLMed.org web site, PROQOLID was
launched at the beginning of 2002.
PROQOLID was created by the systematic collection of
over 470 validated HRQOL and PRO instruments and
their subsequent ordering into categories (e.g. patholo-
gies, conditions, population). Through the structured
presentation of synthesized, reliable and constantly
updated data on PRO instruments, the PROQOLID data-
base aims to present an overview of existing PRO instru-
ments including all relevant and updated information on
each. By providing this information the PROQOLID data-
base facilitates access to the instruments and their devel-
opers and eases the process of selecting the instrument
appropriate for a given application. Instruments can be
chosen through a powerful interactive search function
that will allow for the rapid selection of an appropriate
instrument. What follows is an overview of the proper
usage of the PROQOLID web site through a series of
FAQ's collected directly from users of the web site. The
PROQOLID database can be accessed on the Internet at
http://www.proqolid.org.
PubMed Search: Number of references with Quality of Life-AND-questionnaire from 1966 to 2004 Figure 1
PubMed Search: Number of references with Quality of Life-AND-questionnaire from 1966 to 2004
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Access
What are the differences in access to PROQOLID's 
database between members and guests?
The access to PROQOLID is organized in two levels.
The guest or free level is available to all visitors at no charge. This 
level provides brief information for each instrument, including
• Full name of the instrument and acronym
• Author(s)
• Objective
• Pathology
• Disease
• Type of instrument: Coping, Disability/physical func-
tioning, Health status, Psychosocial/psychological, Qual-
ity of life, Satisfaction, Social functioning, Symptom/
functioning, Utility, Work
• Population: Adolescent, Adult, All, Caregivers, Female,
Geriatrics, Male, Pediatrics, Terminal patients
• Mode of administration: Caregiver-administered, Inter-
viewer-administered, Nurse-rated, Physician-rated, Proxy-
administered, Self-administered, Telephone-administered
• Number of items
• Original language
• List of existing translations
• Existence of a database: Yes / No
• Time recall
Since 1995, Mapi Research Trust has been a non-profit
organization promoting the use and development of
Patient Reported Outcomes. In an effort to accomplish
this, a significant part of PROQOLID has been made
accessible to all users free of charge.
In order to further develop and improve the database and
provide additional information on the available instru-
ments, Mapi Research Trust requests a financial participa-
tion in order to access PROQOLID'S advanced (or
members') level. By subscribing to PROQOLID, you are
supporting the continuous collection and update of this
unique PRO resource. Membership options are available
for pharmaceutical or commercial companies, non-profit
organizations, universities, individual academic research-
ers and students. Benefits to members include a greater
degree of practical information on the instruments and,
when available, includes the review copy of the instru-
ment, its translations and the user manual, most of them
in PDF format.
Detailed information of the advanced level available include for each 
instrument
• Name of the instrument (full and abbreviated)
• Name and contact information of the Authors
• Contact person for information on, or permission to
use, the instrument in its original language
• Copyright information
• Detailed conditions of use (e.g. fee, written permission,
user agreement etc.)
• Review copy of the original instrument (when possible).
Depending on the author's wish, original instruments
may be used under specific conditions such as an access
fee or signed agreement
• Bibliographic references of the original instrument
• Contact person for information on, or permission to use
the translations
• Review copy of the available translations (when
possible)
• Bibliographic references of the available translations
(when possible)
• Dimensions covered by the instrument
• Time for completion
• Age range
• Scoring: response options, available scores, weighting,
score direction and Minimal Important Difference (MID)
or Minimal Clinically Important Difference (MCID)
• Existence of a user manual and copy of the user manual
(when possible)
• Link to the PRO database identification form, when
available
• Methodology of development
• Internal consistency reliabilityHealth and Quality of Life Outcomes 2005, 3:12 http://www.hqlo.com/content/3/1/12
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• Related websites
• Other bibliographic references
Users
Who uses PROQOLID?
The web site is available to anyone having an interest in
the development, availability and use of Patient-Reported
Outcomes (PRO). Through the power of the Internet the
PROQOLID project intends to provide this information
to the world. Every major pharmaceutical company, non-
profit organizations such as the US Food and Drug
Administration, the NIH's National Cancer Institute, the
Veterans Administration as well as dozens of Universities,
researchers and students worldwide subscribe to the
advanced level of PROQOLID on a yearly basis. The PRO-
QOLID database is routinely visited by over 800 users per
day, thereby educating clinicians, researchers, students,
and the world about the availability and proper usage of
PRO instruments.
Content
How are the instruments organized in the PROQOLID 
database?
The PROQOLID database was created in an effort to pro-
vide a means to facilitate the search process for and pro-
vide more efficient searches of any given PRO instrument.
By organizing instruments in the PROQOLID database by
several easy to understand categories, both time and
energy are saved by the user. The different categories can
be located on the Search page of the web site or by access-
ing directly from the tool bar at the top of the page. The
different categories are as follows:
Alphabetical
The purpose of the Alphabetical list is to provide an over-
view of all existing PRO instruments. Over 1000 instru-
ments are listed in alphabetical order according to their
abbreviated name (or acronym). Some of the instruments
are only listed, and these are displayed in standard font.
For the remaining instruments access is available by sim-
ply clicking on the green link containing the abbreviated
name of the instrument. Instruments can be accessed
through an interactive letterbox at the top of the page. For
example if the instrument begins with "D", simply click
on the "D" at the top of the page and all instruments
beginning with that letter will be displayed alphabetically.
Generic Instruments
The generic instruments are listed by alphabetic order on
a separate web page.
Pathology/disease
A specific web page is dedicated to each pathology, and
the instruments are listed either as generic instruments of
the pathology or as disease-specific. The classification is
structured based on Medline's Medical Subject Headings
(MeSH) to ensure that the concepts are widely accepted.
Please note that some diseases may be part of several
pathologies. For example the disease "dementia" is part of
both the pathologies "Neurology" and "Psychiatry/Psy-
chology".
Population
The web page lists the instruments as they apply to specific
populations including Adolescent, Adult, All, Caregivers,
Female, Geriatrics, Male, Pediatrics, and Terminal
patients.
Author's name
Instruments are grouped alphabetically according to the
author's name, and as in the alphabetical list a letterbox is
provided at the top of the page.
Search engine
You may search for instruments according to 10 criteria,
including the name of the instrument, the pathology, the
population or the available languages. The various criteria
may be crossed referenced using the following Boolean
Operators: AND, OR, NOT.
How many instruments are contained in PROQOLID?
The PROQOLID database was developed and is updated
in close collaboration with the instruments' developers. It
currently describes over 470 PRO instruments according
to a structured format. The list is currently growing at the
rate of fifty instruments per year. The database also
includes review copies of 350 original instruments and
350 translations, most of them in PDF format. In order to
determine the available translations simply access the
instrument on the web site and all existing translations are
conveniently listed. Also available through PROQOLID
are over 125 associated User Manuals, and the description
of 80 separate PRO databases. A fifth update of the whole
database is underway and will include new information
for each questionnaire on the reproducibility (or test-
retest reliability) and clinical validity. In addition the
PROQOLID website contains links to 150 external Inter-
net resources relevant to the field of PRO usage and devel-
opment. A general question and answer section on PRO is
also included as well as on line full text articles on the
development, validation, and linguistic adaptation of
many of the PRO instruments published in medical
journals.
What are the instruments criteria to be eligible for 
inclusion in PROQOLID?
To be eligible for inclusion in the database an instrument
must be the subject of a publication that describes its
development and/or validation. There is no charge toHealth and Quality of Life Outcomes 2005, 3:12 http://www.hqlo.com/content/3/1/12
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authors who wish to insert their instruments in PRO-
QOLID nor are authors paid for their participation in this
program. The Mapi Research Trust in Lyon, France deter-
mines ultimate decision for inclusion.
Search
How does the Search Engine work?
Besides the search by categories of instruments listed
above (i.e. alphabetical list, generic, pathology/disease,
population and author's name), an interactive search
engine is included in the PROQOLID web site. All of the
instruments contained on the web site can be accessed
from this location. Searches can be made by:
• Abbreviated Name
• Full Name
• Author
• Pathology
• Disease
• Type of Instrument
• Population
• Mode of Administration
• Inclusion of a PRO Database
• Language
In an effort to increase the effectiveness of each search the
ability exists to include up to nine (9) sub-parameters per
search with the stipulation of "AND" or "OR". For exam-
ple one could enter Author "=" Anderson J "OR" Author
"=" Anderson R "AND" Type of Instrument "=" Quality of
Life, "AND" Language "=" French, or any other combina-
tion that would suit the users needs. Through this func-
tion a user is able to drastically narrow the number of
instruments displayed in the results window, thereby sav-
ing time and effort. If questions exist on the functioning
of the search engine, or any questions about the PRO-
QOLID database a contact page is provided with names
and e-mail addresses for Mapi Research Trust and individ-
ual site managers in both Europe and North America.
Additionally a video including a demo of PROQOLID can
be seen on the home page.
Update
Who maintains the PROQOLID database?
Mapi Research Trust has maintained the PROQOLID
database for three years. The information contained in the
website for each instrument is updated at least once a year
in collaboration with the instruments' developers and
over fifty new instruments are added to the website each
year. Mapi Research Trust has listened to the needs of the
Pharmaceutical Industry, Industry Regulators, health care
professionals, and patients. With the passing of time the
organisation has developed into an intricate team of pro-
fessionals whose single goal is to define and unite the var-
ious requirements of each of these groups in order to
provide better communication and understanding of each
groups needs. PROQOLID achieves to translate these
objectives into a concrete application which ultimate goal
is the improvement of the patients' quality of life and
health outcomes.
Conclusion
The Patient-Reported Outcome and Quality of Life Instru-
ments (PROQOLID) database aims to present an over-
view of existing PRO instruments. PROQOLID currently
describes more than 470 PRO instruments in a structured
format. It includes review copies of over 350 original
instruments, 120 user manuals and 350 translations.
Most are available in PDF format. The database is updated
in close collaboration with the instruments' authors on a
regular basis. Fifty or more new instruments are added
annually. By providing this information the PROQOLID
database facilitates access to the instruments and their
developers and eases the process of selecting the most
appropriate instrument for a given application. Instru-
ments can be chosen through a powerful interactive
search function. The PROQOLID database can be
accessed on the Internet at http://www.proqolid.org.
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